Global Gene Panel

Gene Panel Comprehensive Study by Type (Test Kits, Testing Services), Application (Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics, Others), Design (Predesign, Customized), Technique (Amplicon, Hybridization), End User (Hospital, Research Center, Pharmaceutical Companies) Players and Region - Global Market Outlook to 2030

Gene Panel Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Gene Panel
A gene panel is a test that helps analyze multiple genes for cancer-associated mutations at the same time. BRCA1 and BRCA2 are two genes responsible for producing proteins that help suppress tumors. These proteins help repair damaged DNA and prevent tumor cells from growing. Damaged DNA may not be able to be accurately repaired if any of these genes are mutated or altered, resulting in a condition where cells are more susceptible to developing another genetic mutation that can cause cancer. Both women and men can be analyzed for mutations in the BRCA1 or BRCA2 genes. The analysis also helps assess the risk of developing another type of cancer, including cancer of the fallopian tubes, ovaries, and breasts in women and prostate cancer in men. The global market for gene panels is expected to grow significantly due to the increasing prevalence of chronic diseases around the world. Additionally, an increase in the number of business initiatives around the world and the benefits of Gen Panels are important factors that are expected to propel the Gen Panels market during the forecast period. However, strict rules and regulations for pharmaceutical companies and safety concerns related to genetic data are likely to hamper the market for gene panels in the years to come. Nonetheless, the ongoing research and development in the field of gene sequencing are expected to offer significant opportunities for the development of the market during the forecast period.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Gene Panel market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Illumina, Inc. (United States), BGI Group (China), Agilent Technologies (United States), Eurofins Scientific (Luxembourg), Qiagen (Germany), Genewiz, Inc. (United States), Novogene Corporation (China), Personalis (United States), Thermo Fisher Scientific (United States), F. Hoffmann-La Roche AG (Switzerland), Integrated DNA Technologies (IDT) (United States) and ArcherDx, Inc. (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Gene Panel market by Type (Test Kits and Testing Services), Application (Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Others) and Region.



On the basis of geography, the market of Gene Panel has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Design, the sub-segment i.e. Predesign will boost the Gene Panel market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Technique, the sub-segment i.e. Amplicon will boost the Gene Panel market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospital will boost the Gene Panel market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
The Increasing Number of Clinical and Preclinical Research Studies, Growing Research on Cancer and Inherited Rare Diseases and Increasing Number of NGS-Based & Clinical Applications

Market Growth Drivers:
Rising Prevalence of Chronic Diseases, Growing Company Initiatives, Rising Adoption of Gene Panel Owing To the Benefits They Offer and The Growing Demand for Gene Panel in Research As Well As Diagnostics to Understand the Genetic Variability of Chronic Disorders

Challenges:
Accuracy & Standardization Concerns in Diagnostic Testing

Restraints:
High Cost & Genetic Data Security Issue and Stringent Rules and Regulations for the Pharmaceutical Companies

Opportunities:
Growing Awareness about the Advantages of Gene Panels, The Rising Support for R&D and The Growing Emphasis on Governing and Raising Awareness about These Testing By Governments

Market Leaders and their expansionary development strategies
In February 2024, Myriad Genetics, Inc., a leader in genetic testing and precision medicine,has acquired from Intermountain Health of select assets from its Intermountain Precision Genomics (IPG) laboratory business, including the Precise Tumor Test, the Precise Liquid Test, and IPG’s CLIA-certified laboratory.The acquisition enables Myriad to more effectively scale and grow its tumor profiling offerings to complement its oncology portfolio of hereditary cancer and companion diagnostic testing options.
In May 2023 Vizgen a leader in spatial genomics has Launched Predesigned MERFISH Gene Panels.The PanCancer Pathways Panel features a list of genes targeting canonical signaling pathways of cancer and is constructed using recognized oncology databases, providing a key tool for researchers to study tumor behavior at cellular and subcellular levels across multiple different types of cancers.


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Manufacturers of Gene Panel, Suppliers and Distributors of Gene Panel, Venture Capitalists and Private Equity Firms and End-Use Industry

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Test Kits
  • Testing Services
By Application
  • Cancer Risk Assessment
  • Diagnosis of Congenital Diseases
  • Pharmacogenetics
  • Others
By Design
  • Predesign
  • Customized

By Technique
  • Amplicon
  • Hybridization

By End User
  • Hospital
  • Research Center
  • Pharmaceutical Companies

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Chronic Diseases
      • 3.2.2. Growing Company Initiatives
      • 3.2.3. Rising Adoption of Gene Panel Owing To the Benefits They Offer
      • 3.2.4. The Growing Demand for Gene Panel in Research As Well As Diagnostics to Understand the Genetic Variability of Chronic Disorders
    • 3.3. Market Challenges
      • 3.3.1. Accuracy & Standardization Concerns in Diagnostic Testing
    • 3.4. Market Trends
      • 3.4.1. The Increasing Number of Clinical and Preclinical Research Studies
      • 3.4.2. Growing Research on Cancer and Inherited Rare Diseases
      • 3.4.3. Increasing Number of NGS-Based & Clinical Applications
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Gene Panel, by Type, Application, Design, Technique, End User and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Gene Panel (Value)
      • 5.2.1. Global Gene Panel by: Type (Value)
        • 5.2.1.1. Test Kits
        • 5.2.1.2. Testing Services
      • 5.2.2. Global Gene Panel by: Application (Value)
        • 5.2.2.1. Cancer Risk Assessment
        • 5.2.2.2. Diagnosis of Congenital Diseases
        • 5.2.2.3. Pharmacogenetics
        • 5.2.2.4. Others
      • 5.2.3. Global Gene Panel by: Design (Value)
        • 5.2.3.1. Predesign
        • 5.2.3.2. Customized
      • 5.2.4. Global Gene Panel by: Technique (Value)
        • 5.2.4.1. Amplicon
        • 5.2.4.2. Hybridization
      • 5.2.5. Global Gene Panel by: End User (Value)
        • 5.2.5.1. Hospital
        • 5.2.5.2. Research Center
        • 5.2.5.3. Pharmaceutical Companies
      • 5.2.6. Global Gene Panel Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Gene Panel (Price)
      • 5.3.1. Global Gene Panel by: Type (Price)
  • 6. Gene Panel: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Illumina, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. BGI Group (China)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Agilent Technologies (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Eurofins Scientific (Luxembourg)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Qiagen (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Genewiz, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Novogene Corporation (China)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Personalis (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Thermo Fisher Scientific (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. F. Hoffmann-La Roche AG (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Integrated DNA Technologies (IDT) (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. ArcherDx, Inc. (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Gene Panel Sale, by Type, Application, Design, Technique, End User and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Gene Panel (Value)
      • 7.2.1. Global Gene Panel by: Type (Value)
        • 7.2.1.1. Test Kits
        • 7.2.1.2. Testing Services
      • 7.2.2. Global Gene Panel by: Application (Value)
        • 7.2.2.1. Cancer Risk Assessment
        • 7.2.2.2. Diagnosis of Congenital Diseases
        • 7.2.2.3. Pharmacogenetics
        • 7.2.2.4. Others
      • 7.2.3. Global Gene Panel by: Design (Value)
        • 7.2.3.1. Predesign
        • 7.2.3.2. Customized
      • 7.2.4. Global Gene Panel by: Technique (Value)
        • 7.2.4.1. Amplicon
        • 7.2.4.2. Hybridization
      • 7.2.5. Global Gene Panel by: End User (Value)
        • 7.2.5.1. Hospital
        • 7.2.5.2. Research Center
        • 7.2.5.3. Pharmaceutical Companies
      • 7.2.6. Global Gene Panel Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Gene Panel (Price)
      • 7.3.1. Global Gene Panel by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Gene Panel: by Type(USD Million)
  • Table 2. Gene Panel Test Kits , by Region USD Million (2018-2023)
  • Table 3. Gene Panel Testing Services , by Region USD Million (2018-2023)
  • Table 4. Gene Panel: by Application(USD Million)
  • Table 5. Gene Panel Cancer Risk Assessment , by Region USD Million (2018-2023)
  • Table 6. Gene Panel Diagnosis of Congenital Diseases , by Region USD Million (2018-2023)
  • Table 7. Gene Panel Pharmacogenetics , by Region USD Million (2018-2023)
  • Table 8. Gene Panel Others , by Region USD Million (2018-2023)
  • Table 9. Gene Panel: by Design(USD Million)
  • Table 10. Gene Panel Predesign , by Region USD Million (2018-2023)
  • Table 11. Gene Panel Customized , by Region USD Million (2018-2023)
  • Table 12. Gene Panel: by Technique(USD Million)
  • Table 13. Gene Panel Amplicon , by Region USD Million (2018-2023)
  • Table 14. Gene Panel Hybridization , by Region USD Million (2018-2023)
  • Table 15. Gene Panel: by End User(USD Million)
  • Table 16. Gene Panel Hospital , by Region USD Million (2018-2023)
  • Table 17. Gene Panel Research Center , by Region USD Million (2018-2023)
  • Table 18. Gene Panel Pharmaceutical Companies , by Region USD Million (2018-2023)
  • Table 19. South America Gene Panel, by Country USD Million (2018-2023)
  • Table 20. South America Gene Panel, by Type USD Million (2018-2023)
  • Table 21. South America Gene Panel, by Application USD Million (2018-2023)
  • Table 22. South America Gene Panel, by Design USD Million (2018-2023)
  • Table 23. South America Gene Panel, by Technique USD Million (2018-2023)
  • Table 24. South America Gene Panel, by End User USD Million (2018-2023)
  • Table 25. Brazil Gene Panel, by Type USD Million (2018-2023)
  • Table 26. Brazil Gene Panel, by Application USD Million (2018-2023)
  • Table 27. Brazil Gene Panel, by Design USD Million (2018-2023)
  • Table 28. Brazil Gene Panel, by Technique USD Million (2018-2023)
  • Table 29. Brazil Gene Panel, by End User USD Million (2018-2023)
  • Table 30. Argentina Gene Panel, by Type USD Million (2018-2023)
  • Table 31. Argentina Gene Panel, by Application USD Million (2018-2023)
  • Table 32. Argentina Gene Panel, by Design USD Million (2018-2023)
  • Table 33. Argentina Gene Panel, by Technique USD Million (2018-2023)
  • Table 34. Argentina Gene Panel, by End User USD Million (2018-2023)
  • Table 35. Rest of South America Gene Panel, by Type USD Million (2018-2023)
  • Table 36. Rest of South America Gene Panel, by Application USD Million (2018-2023)
  • Table 37. Rest of South America Gene Panel, by Design USD Million (2018-2023)
  • Table 38. Rest of South America Gene Panel, by Technique USD Million (2018-2023)
  • Table 39. Rest of South America Gene Panel, by End User USD Million (2018-2023)
  • Table 40. Asia Pacific Gene Panel, by Country USD Million (2018-2023)
  • Table 41. Asia Pacific Gene Panel, by Type USD Million (2018-2023)
  • Table 42. Asia Pacific Gene Panel, by Application USD Million (2018-2023)
  • Table 43. Asia Pacific Gene Panel, by Design USD Million (2018-2023)
  • Table 44. Asia Pacific Gene Panel, by Technique USD Million (2018-2023)
  • Table 45. Asia Pacific Gene Panel, by End User USD Million (2018-2023)
  • Table 46. China Gene Panel, by Type USD Million (2018-2023)
  • Table 47. China Gene Panel, by Application USD Million (2018-2023)
  • Table 48. China Gene Panel, by Design USD Million (2018-2023)
  • Table 49. China Gene Panel, by Technique USD Million (2018-2023)
  • Table 50. China Gene Panel, by End User USD Million (2018-2023)
  • Table 51. Japan Gene Panel, by Type USD Million (2018-2023)
  • Table 52. Japan Gene Panel, by Application USD Million (2018-2023)
  • Table 53. Japan Gene Panel, by Design USD Million (2018-2023)
  • Table 54. Japan Gene Panel, by Technique USD Million (2018-2023)
  • Table 55. Japan Gene Panel, by End User USD Million (2018-2023)
  • Table 56. India Gene Panel, by Type USD Million (2018-2023)
  • Table 57. India Gene Panel, by Application USD Million (2018-2023)
  • Table 58. India Gene Panel, by Design USD Million (2018-2023)
  • Table 59. India Gene Panel, by Technique USD Million (2018-2023)
  • Table 60. India Gene Panel, by End User USD Million (2018-2023)
  • Table 61. South Korea Gene Panel, by Type USD Million (2018-2023)
  • Table 62. South Korea Gene Panel, by Application USD Million (2018-2023)
  • Table 63. South Korea Gene Panel, by Design USD Million (2018-2023)
  • Table 64. South Korea Gene Panel, by Technique USD Million (2018-2023)
  • Table 65. South Korea Gene Panel, by End User USD Million (2018-2023)
  • Table 66. Taiwan Gene Panel, by Type USD Million (2018-2023)
  • Table 67. Taiwan Gene Panel, by Application USD Million (2018-2023)
  • Table 68. Taiwan Gene Panel, by Design USD Million (2018-2023)
  • Table 69. Taiwan Gene Panel, by Technique USD Million (2018-2023)
  • Table 70. Taiwan Gene Panel, by End User USD Million (2018-2023)
  • Table 71. Australia Gene Panel, by Type USD Million (2018-2023)
  • Table 72. Australia Gene Panel, by Application USD Million (2018-2023)
  • Table 73. Australia Gene Panel, by Design USD Million (2018-2023)
  • Table 74. Australia Gene Panel, by Technique USD Million (2018-2023)
  • Table 75. Australia Gene Panel, by End User USD Million (2018-2023)
  • Table 76. Rest of Asia-Pacific Gene Panel, by Type USD Million (2018-2023)
  • Table 77. Rest of Asia-Pacific Gene Panel, by Application USD Million (2018-2023)
  • Table 78. Rest of Asia-Pacific Gene Panel, by Design USD Million (2018-2023)
  • Table 79. Rest of Asia-Pacific Gene Panel, by Technique USD Million (2018-2023)
  • Table 80. Rest of Asia-Pacific Gene Panel, by End User USD Million (2018-2023)
  • Table 81. Europe Gene Panel, by Country USD Million (2018-2023)
  • Table 82. Europe Gene Panel, by Type USD Million (2018-2023)
  • Table 83. Europe Gene Panel, by Application USD Million (2018-2023)
  • Table 84. Europe Gene Panel, by Design USD Million (2018-2023)
  • Table 85. Europe Gene Panel, by Technique USD Million (2018-2023)
  • Table 86. Europe Gene Panel, by End User USD Million (2018-2023)
  • Table 87. Germany Gene Panel, by Type USD Million (2018-2023)
  • Table 88. Germany Gene Panel, by Application USD Million (2018-2023)
  • Table 89. Germany Gene Panel, by Design USD Million (2018-2023)
  • Table 90. Germany Gene Panel, by Technique USD Million (2018-2023)
  • Table 91. Germany Gene Panel, by End User USD Million (2018-2023)
  • Table 92. France Gene Panel, by Type USD Million (2018-2023)
  • Table 93. France Gene Panel, by Application USD Million (2018-2023)
  • Table 94. France Gene Panel, by Design USD Million (2018-2023)
  • Table 95. France Gene Panel, by Technique USD Million (2018-2023)
  • Table 96. France Gene Panel, by End User USD Million (2018-2023)
  • Table 97. Italy Gene Panel, by Type USD Million (2018-2023)
  • Table 98. Italy Gene Panel, by Application USD Million (2018-2023)
  • Table 99. Italy Gene Panel, by Design USD Million (2018-2023)
  • Table 100. Italy Gene Panel, by Technique USD Million (2018-2023)
  • Table 101. Italy Gene Panel, by End User USD Million (2018-2023)
  • Table 102. United Kingdom Gene Panel, by Type USD Million (2018-2023)
  • Table 103. United Kingdom Gene Panel, by Application USD Million (2018-2023)
  • Table 104. United Kingdom Gene Panel, by Design USD Million (2018-2023)
  • Table 105. United Kingdom Gene Panel, by Technique USD Million (2018-2023)
  • Table 106. United Kingdom Gene Panel, by End User USD Million (2018-2023)
  • Table 107. Netherlands Gene Panel, by Type USD Million (2018-2023)
  • Table 108. Netherlands Gene Panel, by Application USD Million (2018-2023)
  • Table 109. Netherlands Gene Panel, by Design USD Million (2018-2023)
  • Table 110. Netherlands Gene Panel, by Technique USD Million (2018-2023)
  • Table 111. Netherlands Gene Panel, by End User USD Million (2018-2023)
  • Table 112. Rest of Europe Gene Panel, by Type USD Million (2018-2023)
  • Table 113. Rest of Europe Gene Panel, by Application USD Million (2018-2023)
  • Table 114. Rest of Europe Gene Panel, by Design USD Million (2018-2023)
  • Table 115. Rest of Europe Gene Panel, by Technique USD Million (2018-2023)
  • Table 116. Rest of Europe Gene Panel, by End User USD Million (2018-2023)
  • Table 117. MEA Gene Panel, by Country USD Million (2018-2023)
  • Table 118. MEA Gene Panel, by Type USD Million (2018-2023)
  • Table 119. MEA Gene Panel, by Application USD Million (2018-2023)
  • Table 120. MEA Gene Panel, by Design USD Million (2018-2023)
  • Table 121. MEA Gene Panel, by Technique USD Million (2018-2023)
  • Table 122. MEA Gene Panel, by End User USD Million (2018-2023)
  • Table 123. Middle East Gene Panel, by Type USD Million (2018-2023)
  • Table 124. Middle East Gene Panel, by Application USD Million (2018-2023)
  • Table 125. Middle East Gene Panel, by Design USD Million (2018-2023)
  • Table 126. Middle East Gene Panel, by Technique USD Million (2018-2023)
  • Table 127. Middle East Gene Panel, by End User USD Million (2018-2023)
  • Table 128. Africa Gene Panel, by Type USD Million (2018-2023)
  • Table 129. Africa Gene Panel, by Application USD Million (2018-2023)
  • Table 130. Africa Gene Panel, by Design USD Million (2018-2023)
  • Table 131. Africa Gene Panel, by Technique USD Million (2018-2023)
  • Table 132. Africa Gene Panel, by End User USD Million (2018-2023)
  • Table 133. North America Gene Panel, by Country USD Million (2018-2023)
  • Table 134. North America Gene Panel, by Type USD Million (2018-2023)
  • Table 135. North America Gene Panel, by Application USD Million (2018-2023)
  • Table 136. North America Gene Panel, by Design USD Million (2018-2023)
  • Table 137. North America Gene Panel, by Technique USD Million (2018-2023)
  • Table 138. North America Gene Panel, by End User USD Million (2018-2023)
  • Table 139. United States Gene Panel, by Type USD Million (2018-2023)
  • Table 140. United States Gene Panel, by Application USD Million (2018-2023)
  • Table 141. United States Gene Panel, by Design USD Million (2018-2023)
  • Table 142. United States Gene Panel, by Technique USD Million (2018-2023)
  • Table 143. United States Gene Panel, by End User USD Million (2018-2023)
  • Table 144. Canada Gene Panel, by Type USD Million (2018-2023)
  • Table 145. Canada Gene Panel, by Application USD Million (2018-2023)
  • Table 146. Canada Gene Panel, by Design USD Million (2018-2023)
  • Table 147. Canada Gene Panel, by Technique USD Million (2018-2023)
  • Table 148. Canada Gene Panel, by End User USD Million (2018-2023)
  • Table 149. Mexico Gene Panel, by Type USD Million (2018-2023)
  • Table 150. Mexico Gene Panel, by Application USD Million (2018-2023)
  • Table 151. Mexico Gene Panel, by Design USD Million (2018-2023)
  • Table 152. Mexico Gene Panel, by Technique USD Million (2018-2023)
  • Table 153. Mexico Gene Panel, by End User USD Million (2018-2023)
  • Table 154. Gene Panel: by Type(USD/Units)
  • Table 155. Company Basic Information, Sales Area and Its Competitors
  • Table 156. Company Basic Information, Sales Area and Its Competitors
  • Table 157. Company Basic Information, Sales Area and Its Competitors
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Gene Panel: by Type(USD Million)
  • Table 168. Gene Panel Test Kits , by Region USD Million (2025-2030)
  • Table 169. Gene Panel Testing Services , by Region USD Million (2025-2030)
  • Table 170. Gene Panel: by Application(USD Million)
  • Table 171. Gene Panel Cancer Risk Assessment , by Region USD Million (2025-2030)
  • Table 172. Gene Panel Diagnosis of Congenital Diseases , by Region USD Million (2025-2030)
  • Table 173. Gene Panel Pharmacogenetics , by Region USD Million (2025-2030)
  • Table 174. Gene Panel Others , by Region USD Million (2025-2030)
  • Table 175. Gene Panel: by Design(USD Million)
  • Table 176. Gene Panel Predesign , by Region USD Million (2025-2030)
  • Table 177. Gene Panel Customized , by Region USD Million (2025-2030)
  • Table 178. Gene Panel: by Technique(USD Million)
  • Table 179. Gene Panel Amplicon , by Region USD Million (2025-2030)
  • Table 180. Gene Panel Hybridization , by Region USD Million (2025-2030)
  • Table 181. Gene Panel: by End User(USD Million)
  • Table 182. Gene Panel Hospital , by Region USD Million (2025-2030)
  • Table 183. Gene Panel Research Center , by Region USD Million (2025-2030)
  • Table 184. Gene Panel Pharmaceutical Companies , by Region USD Million (2025-2030)
  • Table 185. South America Gene Panel, by Country USD Million (2025-2030)
  • Table 186. South America Gene Panel, by Type USD Million (2025-2030)
  • Table 187. South America Gene Panel, by Application USD Million (2025-2030)
  • Table 188. South America Gene Panel, by Design USD Million (2025-2030)
  • Table 189. South America Gene Panel, by Technique USD Million (2025-2030)
  • Table 190. South America Gene Panel, by End User USD Million (2025-2030)
  • Table 191. Brazil Gene Panel, by Type USD Million (2025-2030)
  • Table 192. Brazil Gene Panel, by Application USD Million (2025-2030)
  • Table 193. Brazil Gene Panel, by Design USD Million (2025-2030)
  • Table 194. Brazil Gene Panel, by Technique USD Million (2025-2030)
  • Table 195. Brazil Gene Panel, by End User USD Million (2025-2030)
  • Table 196. Argentina Gene Panel, by Type USD Million (2025-2030)
  • Table 197. Argentina Gene Panel, by Application USD Million (2025-2030)
  • Table 198. Argentina Gene Panel, by Design USD Million (2025-2030)
  • Table 199. Argentina Gene Panel, by Technique USD Million (2025-2030)
  • Table 200. Argentina Gene Panel, by End User USD Million (2025-2030)
  • Table 201. Rest of South America Gene Panel, by Type USD Million (2025-2030)
  • Table 202. Rest of South America Gene Panel, by Application USD Million (2025-2030)
  • Table 203. Rest of South America Gene Panel, by Design USD Million (2025-2030)
  • Table 204. Rest of South America Gene Panel, by Technique USD Million (2025-2030)
  • Table 205. Rest of South America Gene Panel, by End User USD Million (2025-2030)
  • Table 206. Asia Pacific Gene Panel, by Country USD Million (2025-2030)
  • Table 207. Asia Pacific Gene Panel, by Type USD Million (2025-2030)
  • Table 208. Asia Pacific Gene Panel, by Application USD Million (2025-2030)
  • Table 209. Asia Pacific Gene Panel, by Design USD Million (2025-2030)
  • Table 210. Asia Pacific Gene Panel, by Technique USD Million (2025-2030)
  • Table 211. Asia Pacific Gene Panel, by End User USD Million (2025-2030)
  • Table 212. China Gene Panel, by Type USD Million (2025-2030)
  • Table 213. China Gene Panel, by Application USD Million (2025-2030)
  • Table 214. China Gene Panel, by Design USD Million (2025-2030)
  • Table 215. China Gene Panel, by Technique USD Million (2025-2030)
  • Table 216. China Gene Panel, by End User USD Million (2025-2030)
  • Table 217. Japan Gene Panel, by Type USD Million (2025-2030)
  • Table 218. Japan Gene Panel, by Application USD Million (2025-2030)
  • Table 219. Japan Gene Panel, by Design USD Million (2025-2030)
  • Table 220. Japan Gene Panel, by Technique USD Million (2025-2030)
  • Table 221. Japan Gene Panel, by End User USD Million (2025-2030)
  • Table 222. India Gene Panel, by Type USD Million (2025-2030)
  • Table 223. India Gene Panel, by Application USD Million (2025-2030)
  • Table 224. India Gene Panel, by Design USD Million (2025-2030)
  • Table 225. India Gene Panel, by Technique USD Million (2025-2030)
  • Table 226. India Gene Panel, by End User USD Million (2025-2030)
  • Table 227. South Korea Gene Panel, by Type USD Million (2025-2030)
  • Table 228. South Korea Gene Panel, by Application USD Million (2025-2030)
  • Table 229. South Korea Gene Panel, by Design USD Million (2025-2030)
  • Table 230. South Korea Gene Panel, by Technique USD Million (2025-2030)
  • Table 231. South Korea Gene Panel, by End User USD Million (2025-2030)
  • Table 232. Taiwan Gene Panel, by Type USD Million (2025-2030)
  • Table 233. Taiwan Gene Panel, by Application USD Million (2025-2030)
  • Table 234. Taiwan Gene Panel, by Design USD Million (2025-2030)
  • Table 235. Taiwan Gene Panel, by Technique USD Million (2025-2030)
  • Table 236. Taiwan Gene Panel, by End User USD Million (2025-2030)
  • Table 237. Australia Gene Panel, by Type USD Million (2025-2030)
  • Table 238. Australia Gene Panel, by Application USD Million (2025-2030)
  • Table 239. Australia Gene Panel, by Design USD Million (2025-2030)
  • Table 240. Australia Gene Panel, by Technique USD Million (2025-2030)
  • Table 241. Australia Gene Panel, by End User USD Million (2025-2030)
  • Table 242. Rest of Asia-Pacific Gene Panel, by Type USD Million (2025-2030)
  • Table 243. Rest of Asia-Pacific Gene Panel, by Application USD Million (2025-2030)
  • Table 244. Rest of Asia-Pacific Gene Panel, by Design USD Million (2025-2030)
  • Table 245. Rest of Asia-Pacific Gene Panel, by Technique USD Million (2025-2030)
  • Table 246. Rest of Asia-Pacific Gene Panel, by End User USD Million (2025-2030)
  • Table 247. Europe Gene Panel, by Country USD Million (2025-2030)
  • Table 248. Europe Gene Panel, by Type USD Million (2025-2030)
  • Table 249. Europe Gene Panel, by Application USD Million (2025-2030)
  • Table 250. Europe Gene Panel, by Design USD Million (2025-2030)
  • Table 251. Europe Gene Panel, by Technique USD Million (2025-2030)
  • Table 252. Europe Gene Panel, by End User USD Million (2025-2030)
  • Table 253. Germany Gene Panel, by Type USD Million (2025-2030)
  • Table 254. Germany Gene Panel, by Application USD Million (2025-2030)
  • Table 255. Germany Gene Panel, by Design USD Million (2025-2030)
  • Table 256. Germany Gene Panel, by Technique USD Million (2025-2030)
  • Table 257. Germany Gene Panel, by End User USD Million (2025-2030)
  • Table 258. France Gene Panel, by Type USD Million (2025-2030)
  • Table 259. France Gene Panel, by Application USD Million (2025-2030)
  • Table 260. France Gene Panel, by Design USD Million (2025-2030)
  • Table 261. France Gene Panel, by Technique USD Million (2025-2030)
  • Table 262. France Gene Panel, by End User USD Million (2025-2030)
  • Table 263. Italy Gene Panel, by Type USD Million (2025-2030)
  • Table 264. Italy Gene Panel, by Application USD Million (2025-2030)
  • Table 265. Italy Gene Panel, by Design USD Million (2025-2030)
  • Table 266. Italy Gene Panel, by Technique USD Million (2025-2030)
  • Table 267. Italy Gene Panel, by End User USD Million (2025-2030)
  • Table 268. United Kingdom Gene Panel, by Type USD Million (2025-2030)
  • Table 269. United Kingdom Gene Panel, by Application USD Million (2025-2030)
  • Table 270. United Kingdom Gene Panel, by Design USD Million (2025-2030)
  • Table 271. United Kingdom Gene Panel, by Technique USD Million (2025-2030)
  • Table 272. United Kingdom Gene Panel, by End User USD Million (2025-2030)
  • Table 273. Netherlands Gene Panel, by Type USD Million (2025-2030)
  • Table 274. Netherlands Gene Panel, by Application USD Million (2025-2030)
  • Table 275. Netherlands Gene Panel, by Design USD Million (2025-2030)
  • Table 276. Netherlands Gene Panel, by Technique USD Million (2025-2030)
  • Table 277. Netherlands Gene Panel, by End User USD Million (2025-2030)
  • Table 278. Rest of Europe Gene Panel, by Type USD Million (2025-2030)
  • Table 279. Rest of Europe Gene Panel, by Application USD Million (2025-2030)
  • Table 280. Rest of Europe Gene Panel, by Design USD Million (2025-2030)
  • Table 281. Rest of Europe Gene Panel, by Technique USD Million (2025-2030)
  • Table 282. Rest of Europe Gene Panel, by End User USD Million (2025-2030)
  • Table 283. MEA Gene Panel, by Country USD Million (2025-2030)
  • Table 284. MEA Gene Panel, by Type USD Million (2025-2030)
  • Table 285. MEA Gene Panel, by Application USD Million (2025-2030)
  • Table 286. MEA Gene Panel, by Design USD Million (2025-2030)
  • Table 287. MEA Gene Panel, by Technique USD Million (2025-2030)
  • Table 288. MEA Gene Panel, by End User USD Million (2025-2030)
  • Table 289. Middle East Gene Panel, by Type USD Million (2025-2030)
  • Table 290. Middle East Gene Panel, by Application USD Million (2025-2030)
  • Table 291. Middle East Gene Panel, by Design USD Million (2025-2030)
  • Table 292. Middle East Gene Panel, by Technique USD Million (2025-2030)
  • Table 293. Middle East Gene Panel, by End User USD Million (2025-2030)
  • Table 294. Africa Gene Panel, by Type USD Million (2025-2030)
  • Table 295. Africa Gene Panel, by Application USD Million (2025-2030)
  • Table 296. Africa Gene Panel, by Design USD Million (2025-2030)
  • Table 297. Africa Gene Panel, by Technique USD Million (2025-2030)
  • Table 298. Africa Gene Panel, by End User USD Million (2025-2030)
  • Table 299. North America Gene Panel, by Country USD Million (2025-2030)
  • Table 300. North America Gene Panel, by Type USD Million (2025-2030)
  • Table 301. North America Gene Panel, by Application USD Million (2025-2030)
  • Table 302. North America Gene Panel, by Design USD Million (2025-2030)
  • Table 303. North America Gene Panel, by Technique USD Million (2025-2030)
  • Table 304. North America Gene Panel, by End User USD Million (2025-2030)
  • Table 305. United States Gene Panel, by Type USD Million (2025-2030)
  • Table 306. United States Gene Panel, by Application USD Million (2025-2030)
  • Table 307. United States Gene Panel, by Design USD Million (2025-2030)
  • Table 308. United States Gene Panel, by Technique USD Million (2025-2030)
  • Table 309. United States Gene Panel, by End User USD Million (2025-2030)
  • Table 310. Canada Gene Panel, by Type USD Million (2025-2030)
  • Table 311. Canada Gene Panel, by Application USD Million (2025-2030)
  • Table 312. Canada Gene Panel, by Design USD Million (2025-2030)
  • Table 313. Canada Gene Panel, by Technique USD Million (2025-2030)
  • Table 314. Canada Gene Panel, by End User USD Million (2025-2030)
  • Table 315. Mexico Gene Panel, by Type USD Million (2025-2030)
  • Table 316. Mexico Gene Panel, by Application USD Million (2025-2030)
  • Table 317. Mexico Gene Panel, by Design USD Million (2025-2030)
  • Table 318. Mexico Gene Panel, by Technique USD Million (2025-2030)
  • Table 319. Mexico Gene Panel, by End User USD Million (2025-2030)
  • Table 320. Gene Panel: by Type(USD/Units)
  • Table 321. Research Programs/Design for This Report
  • Table 322. Key Data Information from Secondary Sources
  • Table 323. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Gene Panel: by Type USD Million (2018-2023)
  • Figure 5. Global Gene Panel: by Application USD Million (2018-2023)
  • Figure 6. Global Gene Panel: by Design USD Million (2018-2023)
  • Figure 7. Global Gene Panel: by Technique USD Million (2018-2023)
  • Figure 8. Global Gene Panel: by End User USD Million (2018-2023)
  • Figure 9. South America Gene Panel Share (%), by Country
  • Figure 10. Asia Pacific Gene Panel Share (%), by Country
  • Figure 11. Europe Gene Panel Share (%), by Country
  • Figure 12. MEA Gene Panel Share (%), by Country
  • Figure 13. North America Gene Panel Share (%), by Country
  • Figure 14. Global Gene Panel: by Type USD/Units (2018-2023)
  • Figure 15. Global Gene Panel share by Players 2023 (%)
  • Figure 16. Global Gene Panel share by Players (Top 3) 2023(%)
  • Figure 17. Global Gene Panel share by Players (Top 5) 2023(%)
  • Figure 18. BCG Matrix for key Companies
  • Figure 19. Illumina, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Illumina, Inc. (United States) Revenue: by Geography 2023
  • Figure 21. BGI Group (China) Revenue, Net Income and Gross profit
  • Figure 22. BGI Group (China) Revenue: by Geography 2023
  • Figure 23. Agilent Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 24. Agilent Technologies (United States) Revenue: by Geography 2023
  • Figure 25. Eurofins Scientific (Luxembourg) Revenue, Net Income and Gross profit
  • Figure 26. Eurofins Scientific (Luxembourg) Revenue: by Geography 2023
  • Figure 27. Qiagen (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Qiagen (Germany) Revenue: by Geography 2023
  • Figure 29. Genewiz, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Genewiz, Inc. (United States) Revenue: by Geography 2023
  • Figure 31. Novogene Corporation (China) Revenue, Net Income and Gross profit
  • Figure 32. Novogene Corporation (China) Revenue: by Geography 2023
  • Figure 33. Personalis (United States) Revenue, Net Income and Gross profit
  • Figure 34. Personalis (United States) Revenue: by Geography 2023
  • Figure 35. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 36. Thermo Fisher Scientific (United States) Revenue: by Geography 2023
  • Figure 37. F. Hoffmann-La Roche AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 38. F. Hoffmann-La Roche AG (Switzerland) Revenue: by Geography 2023
  • Figure 39. Integrated DNA Technologies (IDT) (United States) Revenue, Net Income and Gross profit
  • Figure 40. Integrated DNA Technologies (IDT) (United States) Revenue: by Geography 2023
  • Figure 41. ArcherDx, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 42. ArcherDx, Inc. (United States) Revenue: by Geography 2023
  • Figure 43. Global Gene Panel: by Type USD Million (2025-2030)
  • Figure 44. Global Gene Panel: by Application USD Million (2025-2030)
  • Figure 45. Global Gene Panel: by Design USD Million (2025-2030)
  • Figure 46. Global Gene Panel: by Technique USD Million (2025-2030)
  • Figure 47. Global Gene Panel: by End User USD Million (2025-2030)
  • Figure 48. South America Gene Panel Share (%), by Country
  • Figure 49. Asia Pacific Gene Panel Share (%), by Country
  • Figure 50. Europe Gene Panel Share (%), by Country
  • Figure 51. MEA Gene Panel Share (%), by Country
  • Figure 52. North America Gene Panel Share (%), by Country
  • Figure 53. Global Gene Panel: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Illumina, Inc. (United States)
  • BGI Group (China)
  • Agilent Technologies (United States)
  • Eurofins Scientific (Luxembourg)
  • Qiagen (Germany)
  • Genewiz, Inc. (United States)
  • Novogene Corporation (China)
  • Personalis (United States)
  • Thermo Fisher Scientific (United States)
  • F. Hoffmann-La Roche AG (Switzerland)
  • Integrated DNA Technologies (IDT) (United States)
  • ArcherDx, Inc. (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 236 Pages 77 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Gene Panel Quantitative research analysis
Global Gene Panel Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Illumina, Inc. (United States), BGI Group (China), Agilent Technologies (United States), Eurofins Scientific (Luxembourg), Qiagen (Germany), Genewiz, Inc. (United States), Novogene Corporation (China), Personalis (United States), Thermo Fisher Scientific (United States), F. Hoffmann-La Roche AG (Switzerland), Integrated DNA Technologies (IDT) (United States) and ArcherDx, Inc. (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"The Increasing Number of Clinical and Preclinical Research Studies " is seen as one of major influencing trends for Gene Panel Market during projected period 2023-2030.
The Gene Panel market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Gene Panel Report?

Have a Query? Click Here

Other Related Reports

Medical Digital Imaging Devices Comprehensive Study by Application (General Radiography Application, Dental Application, Fluoroscopy Application, Brain & Neurological MRI Application, Spine & Musculo...
$ 3750
AI for Drug Discovery Comprehensive Study by Drug Type (Small Molecule, Large Molecules), Therapeutic Type (Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases, Others), T...
$ 3650
Scaffold Technology Comprehensive Study by Type (Hydrogels, Polymeric Scaffolds, Nanofiber Based Scaffolds, Micropatterned Surface Microplates), Application (Cancer Cell Research, Stem Cell Research,...
$ 3750
Urgent Care Apps Comprehensive Study by Type (Pre-Hospital Emergency Care Triage Apps, In-Hospital Communication Apps, Post-Hospital Apps (Medication Management Apps, Rehabilitation Apps, Care Provid...
$ 3650
Porokeratosis Treatment Comprehensive Study by Type (Disseminated Superficial Actinic Porokeratosis (DSAP), Mibelli Porokeratosis, Disseminated Superficial Porokeratosis (DSP), Linear Porokeratosis, ...
$ 3500
Bio Process Technology Comprehensive Study by Type (Batch, Fed-batch, Continuous Fermentation, Others), Application (Biopharmaceuticals, Chemical Industry, Others), Technology (Gene Therapy, Cell The...
$ 3800